Michael Bauer

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies
    M Bauer
    Department of Psychiatry, Klinikum Benjamin Franklin, Freie Unversität Berlin, Germany
    J Clin Psychopharmacol 19:427-34. 1999
  2. ncbi World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold
    Michael Bauer
    University of California Los Angeles UCLA, Neuropsychiatric Institute and Hospital, Department of Psychiatry and Biobehavioral Sciences, Los Angeles, CA, USA
    World J Biol Psychiatry 3:69-86. 2002
  3. ncbi Thyroid hormone, neural tissue and mood modulation
    M Bauer
    Neuropsychiatric Institute and Hospital, Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles UCLA, 300 UCLA Medical Plaza, Suite 2330, Los Angeles, CA 90095, USA
    World J Biol Psychiatry 2:59-69. 2001
  4. ncbi Effects of supraphysiological thyroxine administration in healthy controls and patients with depressive disorders
    Michael Bauer
    Department of Psychiatry, Klinikum Benjamin Franklin, Freie Universitat Berlin, Berlin, Germany
    J Affect Disord 68:285-94. 2002
  5. ncbi Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain
    M Bauer
    University of California Los Angeles UCLA, Neuropsychiatric Institute and Hospital, Department of Psychiatry and Biobehavioral Sciences, 760 Westwood Plaza, Los Angeles, CA 90024, USA
    Mol Psychiatry 7:140-56. 2002
  6. ncbi Subjective response to and tolerability of long-term supraphysiological doses of levothyroxine in refractory mood disorders
    M Bauer
    Department of Psychiatry, Klinikum Benjamin Franklin, Freie Universitat Berlin, Berlin, Germany
    J Affect Disord 64:35-42. 2001
  7. ncbi Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression
    M Bauer
    Neuropsychiatric Institute and Hospital, Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, 90095 6968, USA
    Am J Psychiatry 157:1429-35. 2000
  8. ncbi World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder
    Michael Bauer
    Neuropsychiatric Institute and Hospital, Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles ULCA, 300 UCLA Medical Plaza, Suite 2330, Los Angeles, CA 90095, USA
    World J Biol Psychiatry 3:5-43. 2002
  9. ncbi Association between response to lithium augmentation and the combined DEX/CRH test in major depressive disorder
    Tom Bschor
    Department of Psychiatry, Technische Universitat Dresden, Fetscherstrasse 74, D 01307, Dresden, Germany
    J Psychiatr Res 37:135-43. 2003
  10. ncbi Long-term outcome after lithium augmentation in unipolar depression: focus on HPA system activity
    Mazda Adli
    Department of Psychiatry and Psychotherapy, Charite Universitatsmedizin Berlin, Campus Charite Mitte, Berlin, Germany
    Neuropsychobiology 60:23-30. 2009

Detail Information

Publications84

  1. ncbi Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies
    M Bauer
    Department of Psychiatry, Klinikum Benjamin Franklin, Freie Unversität Berlin, Germany
    J Clin Psychopharmacol 19:427-34. 1999
    ..The authors conclude from this meta-analysis that with respect to efficacy, lithium augmentation is the first-choice treatment procedure for depressed patients who fail to respond to antidepressant monotherapy...
  2. ncbi World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold
    Michael Bauer
    University of California Los Angeles UCLA, Neuropsychiatric Institute and Hospital, Department of Psychiatry and Biobehavioral Sciences, Los Angeles, CA, USA
    World J Biol Psychiatry 3:69-86. 2002
    ....
  3. ncbi Thyroid hormone, neural tissue and mood modulation
    M Bauer
    Neuropsychiatric Institute and Hospital, Department of Psychiatry and Biobehavioral Sciences, University of California Los Angeles UCLA, 300 UCLA Medical Plaza, Suite 2330, Los Angeles, CA 90095, USA
    World J Biol Psychiatry 2:59-69. 2001
    ..Also the influence of thyroid hormones on the putative neurotransmitter systems that regulate mood and behaviour, serotonin and norepinephrine, may be helpful in explaining their mood-modulating effects...
  4. ncbi Effects of supraphysiological thyroxine administration in healthy controls and patients with depressive disorders
    Michael Bauer
    Department of Psychiatry, Klinikum Benjamin Franklin, Freie Universitat Berlin, Berlin, Germany
    J Affect Disord 68:285-94. 2002
    ..Unexpectedly, only minimal side effects have been reported. The goal of the present study was to investigate whether healthy controls and depressed patients differ in their ability to tolerate supraphysiological doses of T(4)...
  5. ncbi Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain
    M Bauer
    University of California Los Angeles UCLA, Neuropsychiatric Institute and Hospital, Department of Psychiatry and Biobehavioral Sciences, 760 Westwood Plaza, Los Angeles, CA 90024, USA
    Mol Psychiatry 7:140-56. 2002
    ....
  6. ncbi Subjective response to and tolerability of long-term supraphysiological doses of levothyroxine in refractory mood disorders
    M Bauer
    Department of Psychiatry, Klinikum Benjamin Franklin, Freie Universitat Berlin, Berlin, Germany
    J Affect Disord 64:35-42. 2001
    ..This is the first study to investigate subjective patient response and tolerability to long-term treatment with adjunctive T4...
  7. ncbi Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression
    M Bauer
    Neuropsychiatric Institute and Hospital, Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles, 90095 6968, USA
    Am J Psychiatry 157:1429-35. 2000
    ..The authors examined the efficacy of lithium augmentation in the continuation treatment of unipolar major depressive disorder...
  8. ncbi World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder
    Michael Bauer
    Neuropsychiatric Institute and Hospital, Department of Psychiatry and Biobehavioral Sciences, University of California at Los Angeles ULCA, 300 UCLA Medical Plaza, Suite 2330, Los Angeles, CA 90095, USA
    World J Biol Psychiatry 3:5-43. 2002
    ....
  9. ncbi Association between response to lithium augmentation and the combined DEX/CRH test in major depressive disorder
    Tom Bschor
    Department of Psychiatry, Technische Universitat Dresden, Fetscherstrasse 74, D 01307, Dresden, Germany
    J Psychiatr Res 37:135-43. 2003
    ..Results of this study should be confirmed in a larger study group...
  10. ncbi Long-term outcome after lithium augmentation in unipolar depression: focus on HPA system activity
    Mazda Adli
    Department of Psychiatry and Psychotherapy, Charite Universitatsmedizin Berlin, Campus Charite Mitte, Berlin, Germany
    Neuropsychobiology 60:23-30. 2009
    ....
  11. ncbi Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression
    Tom Bschor
    Department of Psychiatry, Technische Universitat Dresden, Germany
    Depress Anxiety 17:43-8. 2003
    ..This is in contrast to the established decline of HPA system activity during treatment with tricyclic antidepressants...
  12. ncbi Temporal relation between sleep and mood in patients with bipolar disorder
    Michael Bauer
    Department of Psychiatry and Psychotherapy, Charite University Medicine Berlin, Campus Charité Mitte CCM, Berlin, Germany
    Bipolar Disord 8:160-7. 2006
    ..Sleep disturbances are frequent warning signs of both mania and depression. This study used cross correlation analysis to characterize the relationship between mood, sleep and bedrest in longitudinal data...
  13. ncbi Altered representation of expected value in the orbitofrontal cortex in mania
    Felix Bermpohl
    Department of Psychiatry and Psychotherapy, Charite Universitatsmedizin Berlin, Campus Mitte, Berlin, Germany
    Hum Brain Mapp 31:958-69. 2010
    ..Here we studied neural correlates of gain and loss expectation in mania using functional magnetic resonance imaging (fMRI)...
  14. ncbi Bone mineral density during maintenance treatment with supraphysiological doses of levothyroxine in affective disorders: a longitudinal study
    Michael Bauer
    Department of Psychiatry and Psychotherapy, Charite University Medicine Berlin, Campus Charite Mitte, Berlin, Germany
    J Affect Disord 83:183-90. 2004
    ....
  15. ncbi Long-term combination therapy versus monotherapy with lithium and carbamazepine in 46 bipolar I patients
    Christopher Baethge
    Department of Psychiatry, Harvard Medical School, McLean Division of Massachusetts General Hospital, Belmont, MA 02478, USA
    J Clin Psychiatry 66:174-82. 2005
    ..These trials suggest added benefit of combination treatment over use of either agent alone but also indicate the need for further studies...
  16. ncbi Verbal memory retrieval deficits associated with untreated hypothyroidism
    Karen J Miller
    Semel Institute for Neuroscience and Human Behavior, Department of Psychiatry and Behavioral Sciences, University of California, Los Angeles, USA
    J Neuropsychiatry Clin Neurosci 19:132-6. 2007
    ..There were no significant results found between groups on attentional or nonverbal tasks. Results suggest that hypothyroid-related memory deficits are not attributable to an attentional deficit but rather to specific retrieval deficits...
  17. ncbi Supraphysiological doses of L-thyroxine in the maintenance treatment of prophylaxis-resistant affective disorders
    Michael Bauer
    Department of Psychiatry and Psychotherapy, Charite, Humboldt University of Berlin, Berlin, Germany
    Neuropsychopharmacology 27:620-8. 2002
    ..In conclusion, adjunctive treatment with L-thyroxine in supraphysiological doses may be an effective strategy in the maintenance treatment of patients with prophylaxis-resistant affective disorders...
  18. ncbi Response to lithium augmentation in depression is associated with the glycogen synthase kinase 3-beta -50T/C single nucleotide polymorphism
    Mazda Adli
    Department of Psychiatry and Psychotherapy, Charite Universitatsmedizin Berlin, Campus Charite Mitte, Berlin, Germany
    Biol Psychiatry 62:1295-302. 2007
    ..This study investigates the association of the GSK3B -50T/C SNP and response to lithium augmentation in acutely depressed antidepressant nonresponders...
  19. ncbi Hypothalamic-pituitary-thyroid system activity during lithium augmentation therapy in patients with unipolar major depression
    Tom Bschor
    Department of Psychiatry, Technische Universitat Dresden, Dresden, Germany
    J Psychiatry Neurosci 28:210-6. 2003
    ..This study aimed at exploring the role of thyroid function in lithium augmentation and used a prospective design that included a homogeneous sample of inpatients with unipolar major depressive disorder...
  20. ncbi How long should the lithium augmentation strategy be maintained? A 1-year follow-up of a placebo-controlled study in unipolar refractory major depression
    Tom Bschor
    Department of Psychiatry, Technische Universitat Dresden, Dresden, Germany
    J Clin Psychopharmacol 22:427-30. 2002
    ..Study data suggest that active medication should be maintained for at least 1 year after successful lithium augmentation in patients with unipolar major depressive disorder...
  21. ncbi Long-term lithium treatment and thyroid antibodies: a controlled study
    Christopher Baethge
    Department of Psychiatry, Bipolar and Psychotic Disorders Program, Harvard Medical School, McLean Division of Massachusetts General Hospital, Belmont, Mass, USA
    J Psychiatry Neurosci 30:423-7. 2005
    ..TRAb were not found in either group. CONCLUSIONS: In this sample of patients with affective disorders, long-term lithium treatment did not increase the prevalence of thyroid autoimmunity...
  22. ncbi Lithium augmentation therapy in refractory depression-update 2002
    Michael Bauer
    Klinik fur Psychiatrie und Psychotherapie, Charite Campus Mitte Humboldt Universitat zu Berlin, Schumannstr 20 21, 10117, Berlin, Germany
    Eur Arch Psychiatry Clin Neurosci 253:132-9. 2003
    ..Therefore, it should be considered a first-line treatment strategy in patients with major depression who do not adequately respond to standard antidepressants...
  23. ncbi Serotonin transporter gene and response to lithium augmentation in depression
    Thomas J Stamm
    Department of Psychiatry and Psychotherapy, Charite Universitatsmedizin Berlin, Campus Charite Mitte, Berlin, Germany
    Psychiatr Genet 18:92-7. 2008
    ..Lithium augmentation is a well-established strategy for overcoming treatment resistance. In this study, the 5-HTTLPR allele variant's effect on lithium augmentation was analyzed in antidepressant-nonresponsive patients...
  24. ncbi Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm Project
    Katja Wiethoff
    Charite Universitatsmedizin Berlin, Department of Psychiatry and Psychotherapy, Campus Charite Mitte, Berlin, Germany
    J Clin Psychiatry 71:1047-54. 2010
    ..Furthermore, the efficacy of algorithm-guided treatment versus treatment as usual in patients with anxious versus nonanxious depression was evaluated...
  25. ncbi Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up
    Christopher Baethge
    Department of Psychiatry and Psychotherapy, Universitatsklinikum Benjamin Franklin, Freie Universitat Berlin, Eschenallee 3, 14050 Berlin, Germany
    J Affect Disord 79:43-50. 2004
    ....
  26. ncbi Functional neuroanatomy of emotion processing in major depressive disorder is altered after successful antidepressant therapy
    Gabriela Rosenblau
    Department of Psychiatry and Psychotherapy, Campus Charite Mitte, Charite Universitatsmedizin Berlin, Berlin, Germany
    J Psychopharmacol 26:1424-33. 2012
    ..These findings show that the neural mechanisms of emotion anticipation and processing are altered in patients with MDD and that these alterations are able to normalize after treatment with an antidepressant...
  27. ncbi Hyporeactivity of ventral striatum towards incentive stimuli in unmedicated depressed patients normalizes after treatment with escitalopram
    Meline Stoy
    Department of Psychiatry and Psychotherapy, Campus Charite Mitte, Charite Universitatsmedizin Berlin, Berlin, Germany
    J Psychopharmacol 26:677-88. 2012
    ..These findings suggest that MDD patients show ventral striatal hyporesponsiveness during incentive cue processing, which normalizes after successful treatment...
  28. ncbi Long-term treatment with supraphysiological doses of thyroid hormone in affective disorders - effects on bone mineral density
    Roland Ricken
    Department of Psychiatry and Psychotherapy, Charite Universitatsmedizin Berlin, Campus Mitte, Berlin, Germany
    J Affect Disord 136:e89-94. 2012
    ..To investigate the long-term effects of supraphysiological, TSH suppressive doses of levothyroxine (TSDL) on bone mineral density (BMD) in patients with affective disorders during an average treatment duration of 69 months...
  29. ncbi Lithium augmentation increases the ACTH and cortisol response in the combined DEX/CRH test in unipolar major depression
    Tom Bschor
    Department of Psychiatry, Technische Universitat Dresden, Dresden, Germany
    Neuropsychopharmacology 27:470-8. 2002
    ..This effect might be explained by the serotonergic effects of lithium...
  30. ncbi Using technology to improve longitudinal studies: self-reporting with ChronoRecord in bipolar disorder
    Michael Bauer
    Department of Psychiatry and Psychotherapy, Charite University Medicine Berlin, Berlin, Germany
    Bipolar Disord 6:67-74. 2004
    ....
  31. ncbi A preliminary study of increased amygdala activation to positive affective stimuli in mania
    Felix Bermpohl
    Department of Psychiatry and Psychotherapy, Charite Universitatsmedizin Berlin, Berlin, Germany
    Bipolar Disord 11:70-5. 2009
    ..The present study in hypomanic and manic patients explored how amygdala responses to affective stimuli depend on the valence of the stimuli presented...
  32. ncbi Hallucinations in bipolar disorder: characteristics and comparison to unipolar depression and schizophrenia
    Christopher Baethge
    Department of Psychiatry, International Consortium for Bipolar Disorder Research, Harvard Medical School, McLean Division of Massachusetts General Hospital, Belmont, MA 02478 9106, USA
    Bipolar Disord 7:136-45. 2005
    ..As there is very little research on the topic, we compared the frequency and the type hallucinations among hospitalized patients diagnosed with bipolar disorder (BPD) versus other major psychiatric illnesses...
  33. ncbi Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate
    Jens M Langosch
    Department of Psychiatry, Albert Ludwigs University of Freiburg, Freiburg, Germany
    J Clin Psychopharmacol 28:555-60. 2008
    ..The aim of this study was to examine the long-term efficacy and safety of a monotherapy with quetiapine or sodium valproate (VPA) in patients with rapid-cycling bipolar disorder...
  34. ncbi Early mood swings as symptoms of the bipolar prodrome: preliminary results of a retrospective analysis
    Seza Ozgurdal
    Department of Psychiatry, Ruhr University Bochum, LWL University Hospital Bochum, Bochum, Germany
    Psychopathology 42:337-42. 2009
    ..The aim of this study was to investigate the relationship between affective temperament and mood swings in bipolar disorder. We explored these clinical features retrospectively...
  35. ncbi Switching schizophrenia patients from typical neuroleptics to olanzapine: effects on BOLD response during attention and working memory
    Florian Schlagenhauf
    Department of Psychiatry, Charite Universitaetsmedizin Berlin, Campus Mitte, Germany
    Eur Neuropsychopharmacol 18:589-99. 2008
    ..However, medication status had influences on the activation during attentional task (0-back), emphasizing the importance of baseline selection in pharmacological fMRI studies...
  36. ncbi Epidemiology of bipolar disorders
    Michael Bauer
    Charite University Medicine Berlin, Campus Charité Mitte CCM, Department of Psychiatry and Psychotherapy, Berlin, Germany
    Epilepsia 46:8-13. 2005
    ..Interdisciplinary knowledge transfer could help to increase our understanding of the pathophysiology of these disorders as well as provide grounds for better recognition and treatment of patients with manic and/or depressive symptoms...
  37. ncbi Commentary on a recent review of lithium toxicity: what are its implications for clinical practice?
    Bruno Muller-Oerlinghausen
    Drug Commission of the German Medical Association, Berlin, Germany
    BMC Med 10:132. 2012
    ..We feel that some specific limitations of the study were related to the inclusion of patients regardless of adequacy of treatment, quality of monitoring, drug combinations, age and sex, and stabilization response...
  38. ncbi Early recognition of bipolar disorder
    Marta Hauser
    Early Recognition Center of Beginning Psychoses, Department of Psychiatry, Charite, Campus Mitte, Berlin, Germany
    Eur Psychiatry 22:92-8. 2007
    ..This will require prospective studies to determine the predictive power of the risk factors integrated into the scale...
  39. ncbi Memory improvement with treatment of hypothyroidism
    Karen J Miller
    Department of Psychiatry and Biobehavioral Sciences, UCLA NPI-H, Los Angeles, California, USA
    Int J Neurosci 116:895-906. 2006
    ..Results suggest that specific memory retrieval deficits associated with hypothyroidism can resolve after replacement therapy with levothyroxine...
  40. ncbi Thyroid hypofunction in patients with rapid-cycling bipolar disorder after lithium challenge
    Laszlo Gyulai
    Bipolar Disorders Program, Department of Psychiatry, University of Pennsylvania, Philadelphia 19104, USA
    Biol Psychiatry 53:899-905. 2003
    ..CONCLUSIONS: Rapid-cycling BD is associated with a latent hypofunction of the HPT system. This dysfunction becomes manifest with short-term lithium challenge...
  41. ncbi Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials
    Nicolas Andres Crossley
    Department of Psychiatry and Psychotherapy, Charite University Medicine Berlin, Campus Charite Mitte, Berlin, Germany
    J Clin Psychiatry 68:935-40. 2007
    ..Outcomes investigated included response rates and depression scale rates...
  42. ncbi Thyroid hormone and mood modulation: new insights from functional brain imaging techniques
    Michael Bauer
    Department of Psychiatry and Behavioral Sciences, Neuropsychiatric Institute and Hospital, University of California at Los Angeles, 760 Westwood Plaza, Los Angeles, CA 90024, USA
    Curr Psychiatry Rep 5:163-5. 2003
  43. ncbi Effects of supraphysiological doses of L-thyroxine on cognitive function in healthy individuals
    Christopher Baethge
    Department of Psychiatry, Klinikum Benjamin Franklin, , Eschenallee 3, 14050 Berlin, Germany
    Psychiatry Res 110:117-23. 2002
    ..The results of this study do not support our working hypothesis that thyroid hormone can change cognitive performance in young, euthyroid, healthy individuals...
  44. ncbi Diagnostic guidelines for bipolar disorder: a summary of the International Society for Bipolar Disorders Diagnostic Guidelines Task Force Report
    S Nassir Ghaemi
    Bipolar Disorder Research Program, Department of Psychiatry, Emory University, Atlanta, GA 30322, USA
    Bipolar Disord 10:117-28. 2008
    ....
  45. ncbi Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement
    Hans Jurgen Moller
    Department of Psychiatry, Ludwig Maximilians University Munchen, Nussbaumstrasse 7, 80336 Munich, Germany
    Eur Arch Psychiatry Clin Neurosci 258:3-23. 2008
    ..It is the major problem facing efforts to identify the possible 'suicidal effects' of antidepressants...
  46. ncbi Peripheral thyroid hormones and response to selective serotonin reuptake inhibitors
    Michael Gitlin
    Department of Psychiatry, UCLA School of Medicine, Los Angeles, CA 90095, USA
    J Psychiatry Neurosci 29:383-6. 2004
    ..To examine the relation between baseline measurements of thyroid function and response to selective serotonin reuptake inhibitors (SSRIs) and to consider the effect of these antidepressants on thyroid hormone levels...
  47. ncbi Neurocognitive impairment and dementia in mood disorders
    Andrea Pfennig
    Department of Psychiatry and Psychotherapy, Charite University Medicine Berlin, Campus Mitte, Berlin, Germany
    J Neuropsychiatry Clin Neurosci 19:373-82. 2007
    ..Ideas on pathophysiological causation and progression are translated into recommendations for patient management...
  48. ncbi Bipolar disorder
    Bruno Muller-Oerlinghausen
    Department of Psychiatry, Research Group of Clinical Psychopharmacology, Freie Universitat Berlin, Berlin
    Lancet 359:241-7. 2002
    ..They also possess well documented antisuicidal effects. Second choice prophylactic treatments are carbamazepine and valproate, although evidence of their effectiveness is weaker...
  49. ncbi Efficacy of a systematic depression management program in high utilizers of primary care: a randomized trial
    Anne Berghöfer
    Institute for Social Medicine, Epidemiology and Health Economics, Charite University Medical Center, Berlin, Germany
    BMC Health Serv Res 12:298. 2012
    ..This study aims to examine the effects of a systematic screening and collaborative treatment program on depression severity in small primary care practices of the German outpatient health care system...
  50. ncbi Algorithms and collaborative-care systems for depression: are they effective and why? A systematic review
    Mazda Adli
    Department of Psychiatry and Psychotherapy, Charite Universitatsmedizin Berlin, Campus Charite Mitte, Berlin, Germany
    Biol Psychiatry 59:1029-38. 2006
    ....
  51. ncbi Menstrual cycle related mood changes in women with bipolar disorder
    Natalie Rasgon
    Department of Psychiatry and Biobehavioral Sciences, Neuropsychiatric Institute and Hospital, University of California Los Angeles, CA, USA
    Bipolar Disord 5:48-52. 2003
    ..This study investigates the influence of the menstrual cycle on mood in women with BPD who are taking medication, but not selected for menstrual abnormalities...
  52. ncbi Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials
    Florian Seemüller
    Department of Psychiatry and Psychotherapy, Ludwig Maximilian University Munich, Munich, Germany
    J Clin Psychiatry 71:1425-33. 2010
    ..Because of strict inclusion and exclusion criteria, results drawn from placebo-controlled randomized antidepressant efficacy trials may not be transferable to real-world patients...
  53. ncbi Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study
    Michael Bauer
    Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universitat Dresden, Fetscherstrasse 74, D 01307 Dresden, Germany
    Eur Psychiatry 23:66-73. 2008
    ..In conclusion, the prescribing of antidepressants varies by country, and the type of antidepressant chosen is influenced by physician- as well as patient-related factors...
  54. ncbi Effectiveness and outcome predictors of long-term lithium prophylaxis in unipolar major depressive disorder
    Christopher Baethge
    Consolidated Department of Psychiatry, Harvard Medical School, The Bipolar and Psychotic Disorders Program, McLean Division of Massachusetts General Hospital, Belmont, Mass 02478 9106, USA
    J Psychiatry Neurosci 28:355-61. 2003
    ..To determine the effectiveness of lithium prophylaxis in unipolar major depressive disorder (MDD) and to identify predictors of outcome including comedication...
  55. ncbi Rapid cycling bipolar disorder--diagnostic concepts
    Michael Bauer
    Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universitat Dresden, Dresden, Germany
    Bipolar Disord 10:153-62. 2008
    ..This paper reviews the literature to examine the DSM-IV diagnostic criteria for rapid cycling in bipolar disorder...
  56. ncbi World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care
    Michael Bauer
    University Hospital Carl Gustav Carus, Department of Psychiatry and Psychotherapy, Technische Universitat Dresden, Dresden, Germany
    World J Biol Psychiatry 8:67-104. 2007
    ..They deal primarily with biological treatment (including antidepressants, other psychopharmacological and hormonal medications, electroconvulsive therapy, light therapy)...
  57. ncbi Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review
    Mazda Adli
    Department of Psychiatry and Psychotherapy, Charite Universitatsmedizin Berlin, Campus Charite Mitte, Germany
    Eur Arch Psychiatry Clin Neurosci 255:387-400. 2005
    ..e. augmentation or change of compound) are lacking. The aim of this publication is to review available direct and indirect evidence concerning dose increase of antidepressants after a medium-dose trial has failed...
  58. ncbi Efficacy and mechanisms of action of lithium augmentation in refractory major depression
    Tom Bschor
    Department of Psychiatry and Psychotherapy, Jewish Hospital Berlin, Heinz Galinski Str 1, D 13347 Berlin, Germany
    Curr Pharm Des 12:2985-92. 2006
    ..In international treatment guidelines and algorithms, lithium augmentation is considered a first-line treatment strategy for patients with a major depressive episode who do not adequately respond to standard antidepressant treatment...
  59. ncbi Mood changes related to antidepressants: a longitudinal study of patients with bipolar disorder in a naturalistic setting
    Michael Bauer
    Department of Psychiatry and Psychotherapy, Charite University Medicine Berlin, Campus Charite Mitte, Schumannstr 20 21, 10117 Berlin, Germany
    Psychiatry Res 133:73-80. 2005
    ..The primary difference in pattern between the groups was the time spent in depressed or normal mood, with minor daily mood variations...
  60. ncbi Effectiveness and feasibility of a standardized stepwise drug treatment regimen algorithm for inpatients with depressive disorders: results of a 2-year observational algorithm study
    Mazda Adli
    Department of Psychiatry and Psychotherapy, , , Germany
    J Clin Psychiatry 63:782-90. 2002
    ..Most importantly, algorithm-guided antidepressive treatment showed a favorable response in those depressed patients who were treated according to the SSTR protocol...
  61. ncbi Thyroid hormone augmentation with levothyroxine in bipolar depression
    Michael Bauer
    Department of Psychiatry and Psychotherapy, Charit, Humbo dt Univers ty Berlin, Germany
    Bipolar Disord 4:109-10. 2002
  62. ncbi Hypothalamic-pituitary-end organ function in women with bipolar depression
    Natalie L Rasgon
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, CA 94305 5723, USA
    Psychoneuroendocrinology 32:279-86. 2007
    ..The results are preliminary, and require replication in larger samples...
  63. ncbi Using ultrasonography to determine thyroid size and prevalence of goiter in lithium-treated patients with affective disorders
    Michael Bauer
    Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universitat Dresden, Dresden, Germany
    J Affect Disord 104:45-51. 2007
    ..To determine thyroid gland volume and the prevalence of goiter in patients receiving long-term lithium treatment for affective disorders...
  64. ncbi Glucose utilization in the medial prefrontal cortex correlates with serotonin turnover rate and clinical depression in alcoholics
    Wendol Williams
    National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA
    Psychiatry Res 132:219-24. 2004
    ..This pilot study indicates that a dysfunction of medial PFC may interact with central serotonin turnover and negative mood states during early abstinence...
  65. ncbi Is successful lithium augmentation limited to serotonergic antidepressants?
    Tom Bschor
    J Clin Psychopharmacol 24:240-1; author reply 241-2. 2004
  66. ncbi A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder
    David G S Perahia
    Lilly Research Centre, Erl Wood, Sunninghill Road, Windlesham, Surrey GU20 6PH, UK
    J Psychiatr Res 42:22-34. 2008
    ..The objective was to compare the serotonin and norepinephrine reuptake inhibitors (SNRIs) duloxetine and venlafaxine using GBR assessment...
  67. ncbi Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms
    Michael Bauer
    Department of Psychiatry and Psychotherapy, Charite University Hospital, Humboldt University at Berlin, Schumannstr 20 21, 10117 Berlin, Germany
    Can J Psychiatry 48:440-8. 2003
    ..It also examines hypotheses on the mode of action of lithium augmentation, with a focus on serotonin (5-HT) and neuroendocrine systems, and proposes recommendations for future research...
  68. ncbi Sex-specific self-reported mood changes by patients with bipolar disorder
    Natalie Rasgon
    Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Room 2360, Palo Alto, CA 94305-5723, USA
    J Psychiatr Res 39:77-83. 2005
    ..CONCLUSIONS: The clinical course of bipolar disorder differed between the sexes. Women reported depression and large fluctuations in mood more frequently than men. Women also experienced mood changes across the menstrual cycle...
  69. ncbi Prophylaxis latency and outcome in bipolar disorders
    Christopher Baethge
    Consolidated Department of Psychiatry, Harvard Medical School, Bipolar and Psychotic Disorders Program, McLean Division of Massachusetts General Hospital, Belmont, Massachusetts, USA
    Can J Psychiatry 48:449-57. 2003
    ..To analyze new and reviewed findings to evaluate relations between treatment response and latency from onset of bipolar disorder (BD) to the start of mood-stabilizer prophylaxis...
  70. ncbi Iloprost ameliorates post-ischemic lung reperfusion injury and maintains an appropriate pulmonary ET-1 balance
    Masahiro Kawashima
    Department of Thoracic and Cardiovascular Surgery, University of Saarland, Homburg/Saar, Germany
    J Heart Lung Transplant 22:794-801. 2003
    ..CONCLUSIONS: We demonstrated in an isolated lung perfusion model that iloprost ameliorates post-ischemic lung reperfusion injury and maintains an appropriate pulmonary ET-1 balance...
  71. ncbi Longitudinal evaluation of reproductive function in women treated for bipolar disorder
    Natalie L Rasgon
    Department of Psychiatry and Behavioral Sciences, Stanford School of Medicine, Stanford University, 401 Quarry Road, Palo Alto, Ca 94305 5723 Stanford, California, United States
    J Affect Disord 89:217-25. 2005
    ..We assessed reproductive endocrine and metabolic markers in women treated for bipolar disorder over a 2-year time period, controlling for valproate use...
  72. ncbi Does the use of an automated tool for self-reporting mood by patients with bipolar disorder bias the collected data?
    Michael Bauer
    Department of Psychiatry and Psychotherapy, Charite University Medicine Berlin, Campus Charite Mitte, Germany
    MedGenMed 7:21. 2005
    ..Automating data collection from patients can improve data quality, enhance compliance, and decrease costs in longitudinal studies. About half of all households in industrialized countries now have a home computer...
  73. ncbi Duloxetine: a new selective and dual-acting antidepressant
    Michael Bauer
    Department of Psychiatry and Psychotherapy, , , Schumannstrasse 20/21, D-10117 Berlin, Germany
    Expert Opin Pharmacother 7:421-7. 2006
    ..Therefore, duloxetine provides an alternative to current therapeutic options in the treatment of the different symptoms of depression...
  74. ncbi Updated WFSBP Guidelines for the Biological Treatment of Unipolar Depressive Disorders in Primary Care
    Michael Bauer
    World J Biol Psychiatry 8:66. 2007
  75. ncbi [Modern antidepressant treatment]
    Max Pilhatsch
    Klinik fur Psychiatrie und Psychotherapie, Universitatsklinikum Carl Gustav Carus, Technische Universitat Dresden, Fetscherstrasse 74, 01307 Dresden
    Psychiatr Prax 34:S281-6. 2007
    ..A systematic review on empirical results of current guidelines and recommendations with focus on efficacy and tolerability of antidepressant pharmacological treatment options...
  76. ncbi Factors influencing depression endpoints research (FINDER): study design and population characteristics
    Ana Garcia-Cebrian
    Eli Lilly and Company Limited, Lilly Research Centre, Erl Wood Manor, Sunninghill Road, Windlesham, Surrey GU20 6PH, UK
    Eur Psychiatry 23:57-65. 2008
    ..Further investigation into factors associated with HRQoL in depression after treatment initiation is warranted...
  77. ncbi Awareness of metabolic concerns in patients with bipolar disorder: a survey of European psychiatrists
    Michael Bauer
    Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universitat Dresden, Fetscherstrasse 74, D 01307 Dresden, Germany
    Eur Psychiatry 23:169-77. 2008
    ..An online survey of European psychiatrists assessed awareness of the metabolic syndrome and its influence on the management of bipolar disorder...
  78. ncbi World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia
    Rajiv Tandon
    University of Florida, Tallahassee, USA
    Schizophr Res 100:20-38. 2008
    ....
  79. ncbi Self-reported data from patients with bipolar disorder: frequency of brief depression
    Michael Bauer
    Department of Psychiatry and Psychotherapy, Universitatsklinikum Carl Gustav Carus, Technische Universitat Dresden, Germany
    J Affect Disord 101:227-33. 2007
    ..Using daily self-reported mood ratings, we studied how changing the length requirement to that typical of recurrent brief depression (2-4 days) would impact the number of depressed episodes...
  80. ncbi Approximate entropy of self-reported mood prior to episodes in bipolar disorder
    Tasha Glenn
    ChronoRecord Association, Inc, Fullerton, CA 92834, USA
    Bipolar Disord 8:424-9. 2006
    ....
  81. ncbi Self-reporting software for bipolar disorder: validation of ChronoRecord by patients with mania
    Michael Bauer
    Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universitat Dresden, Fetscherstr 74, 01307 Dresden, Germany
    Psychiatry Res 159:359-66. 2008
    ..Post-hoc analysis of the level of agreement between ChronoRecord and YMRS ratings was excellent or good in all cases using the kappa statistic. These data demonstrate concurrent validity between ChronoRecord and YMRS...
  82. ncbi Self-reported data from patients with bipolar disorder: impact on minimum episode length for hypomania
    Michael Bauer
    Department of Psychiatry and Psychotherapy, Charite University Medicine Berlin, Campus Charité Mitte CCM, Schumannstr 20 21, 10117 Berlin, Germany
    J Affect Disord 96:101-5. 2006
    ..Using daily self-reported mood ratings, we studied the impact of changing the length requirement on the number of hypomanic episodes in patients with bipolar disorder...
  83. ncbi Changes in self-reported sleep duration predict mood changes in bipolar disorder
    Michael Bauer
    Psychol Med 38:1069-71. 2008